BG103881A - Метод за получаване на флурбипрофенови пастили - Google Patents

Метод за получаване на флурбипрофенови пастили

Info

Publication number
BG103881A
BG103881A BG103881A BG10388199A BG103881A BG 103881 A BG103881 A BG 103881A BG 103881 A BG103881 A BG 103881A BG 10388199 A BG10388199 A BG 10388199A BG 103881 A BG103881 A BG 103881A
Authority
BG
Bulgaria
Prior art keywords
mixture
fuelbiprophene
pasties
obtaining
pastill
Prior art date
Application number
BG103881A
Other languages
Bulgarian (bg)
English (en)
Inventor
Andrew Day
Huw Jones
Carl Smith
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of BG103881A publication Critical patent/BG103881A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG103881A 1997-05-22 1999-11-15 Метод за получаване на флурбипрофенови пастили BG103881A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process
PCT/EP1998/003167 WO1998052539A1 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Publications (1)

Publication Number Publication Date
BG103881A true BG103881A (bg) 2000-05-31

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103881A BG103881A (bg) 1997-05-22 1999-11-15 Метод за получаване на флурбипрофенови пастили

Country Status (31)

Country Link
US (1) US6194003B1 (cs)
EP (1) EP0983059B1 (cs)
JP (1) JP2001527567A (cs)
KR (1) KR20010012739A (cs)
CN (1) CN1154480C (cs)
AR (1) AR015812A1 (cs)
AT (1) ATE245021T1 (cs)
AU (1) AU725760B2 (cs)
BG (1) BG103881A (cs)
BR (1) BR9809651A (cs)
CA (1) CA2290830C (cs)
CZ (1) CZ290816B6 (cs)
DE (1) DE69816440T2 (cs)
DK (1) DK0983059T3 (cs)
ES (1) ES2202871T3 (cs)
GB (1) GB9710521D0 (cs)
HU (1) HU224954B1 (cs)
ID (1) ID22949A (cs)
IL (1) IL132999A0 (cs)
IN (1) IN187837B (cs)
MY (1) MY118410A (cs)
NO (1) NO995681L (cs)
NZ (1) NZ500664A (cs)
PL (1) PL190947B1 (cs)
PT (1) PT983059E (cs)
RU (1) RU2203046C2 (cs)
SK (1) SK283701B6 (cs)
TR (1) TR199902725T2 (cs)
UA (1) UA53714C2 (cs)
WO (1) WO1998052539A1 (cs)
ZA (1) ZA984260B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60027761T2 (de) 1999-12-09 2007-01-25 Reckitt Benckiser Healthcare (Uk) Ltd., Slough Komprimierte zubereitung enthaltend nichtsteroidale entzündungshemmer
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
JP2007528857A (ja) * 2003-07-11 2007-10-18 ミリアド ジェネティクス， インコーポレイテッド アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
NZ556465A (en) 2005-02-03 2010-10-29 Nycomed Pharma As Fast wet-massing method for the preparation of calcium-containing compositions
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
JP2009502807A (ja) * 2005-07-22 2009-01-29 ミリアド ジェネティクス， インコーポレイテッド 薬剤含有率の高い製剤および投与量形態
CA2620219A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
CA2680238A1 (en) * 2007-07-23 2009-01-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
MX344359B (es) * 2008-08-22 2016-12-14 Reckitt Benckiser Healthcare (Uk) Ltd Composición particulada ingerible para el dolor de garganta.
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
RS61753B1 (sr) 2011-04-29 2021-05-31 Moberg Pharma Ab Farmaceutske kompozicije koje sadrže lokalni anestetik kao što je bupivakain za lokalno administriranje u usta ili grlo
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
WO2017029710A1 (ja) * 2015-08-18 2017-02-23 合同会社Ｐｈａｒｍａ Ｓｅｅｄｓ Ｃｒｅａｔｅ ＮＳＡＩＤｓまたはヘパリン類含有口腔用組成物
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
RU2026670C1 (ru) * 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1244698B (it) * 1991-02-01 1994-08-08 Gentili Ist Spa Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
US5302394A (en) 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
ID22949A (id) 1999-12-16
ZA984260B (en) 1999-02-20
CA2290830A1 (en) 1998-11-26
PL336624A1 (en) 2000-07-03
UA53714C2 (uk) 2003-02-17
SK158899A3 (en) 2000-05-16
PT983059E (pt) 2003-11-28
PL190947B1 (pl) 2006-02-28
NZ500664A (en) 2001-01-26
DK0983059T3 (da) 2003-11-03
GB9710521D0 (en) 1997-07-16
WO1998052539A1 (en) 1998-11-26
IL132999A0 (en) 2001-03-19
NO995681D0 (no) 1999-11-19
NO995681L (no) 1999-11-19
RU2203046C2 (ru) 2003-04-27
HUP0002121A2 (hu) 2000-12-28
IN187837B (cs) 2002-06-29
CN1255848A (zh) 2000-06-07
CZ412099A3 (cs) 2000-02-16
KR20010012739A (ko) 2001-02-26
ES2202871T3 (es) 2004-04-01
AU7916598A (en) 1998-12-11
TR199902725T2 (xx) 2000-02-21
AR015812A1 (es) 2001-05-30
SK283701B6 (sk) 2003-12-02
CA2290830C (en) 2006-07-11
MY118410A (en) 2004-10-30
DE69816440D1 (de) 2003-08-21
ATE245021T1 (de) 2003-08-15
AU725760B2 (en) 2000-10-19
HUP0002121A3 (en) 2001-04-28
CZ290816B6 (cs) 2002-10-16
BR9809651A (pt) 2000-07-11
EP0983059B1 (en) 2003-07-16
EP0983059A1 (en) 2000-03-08
US6194003B1 (en) 2001-02-27
JP2001527567A (ja) 2001-12-25
HU224954B1 (en) 2006-04-28
CN1154480C (zh) 2004-06-23
DE69816440T2 (de) 2004-05-13

Similar Documents

Publication Publication Date Title
BG103881A (bg) Метод за получаване на флурбипрофенови пастили
DE69123075D1 (de) Ueberzogene Zusammensetzung sowie Verfahren zu ihrer Herstellung
DE69216642D1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
SE8303531D0 (sv) Farmaceutisk komposition
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
DZ2465A1 (fr) Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions les contenant.
IT1197592B (it) Derivati di 3-cheto delta 4,9 19-nor-steroidi,procedimento per la loro preparazione,loro impiego come medicamenti,composizioni che li contengono ed intermedi ottenuti
JPS5558096A (en) Method of making novel recombined dna
IE870112L (en) Fused benzazepines and intermediates thereof
IT8421821V0 (it) Struttura di blocco di iniezione per l'alimentazione di stampi con materiale termoplatisco fuso.
ES2152379T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
FR2567884B1 (fr) Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
MX9203140A (es) Derivados de 4 fenil-4(n-(fenil)amido)-piperidina y las composiciones farmaceuticas, asi como el metodo aplicado para tales compuestos.
FR2556721B1 (fr) Nouveaux derives de o-mercaptopropanamide d'o amino-acides, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
TW350773B (en) Melted granulated preparation of sucralfate for the treatment of digestic ulcer and its manufacturing method thereof
NO20005360D0 (no) Sammensetning for fremstilling av brennstoffbriketter
AU8862098A (en) Method for producing ceramic fibers, the fibers thus produced and their use
GR3001800T3 (en) 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivative, process for the production thereof, pharmaceutical composition and intermediates
FR2769839B1 (fr) Composition anhydre a base de lactulose
JPS56122357A (en) 7*88amino*hydroxyy11phenyll2*3*4*55tetrahydroo 1hh33bezazepines* their manufacture and medicinal composition containing them
IT1150024B (it) 4-fenil-4,5,6,7-tetraidropirrolo(2,3-c) piridine,procedimento per la loro fabbricazione,nonche'composizioni farmaceutiche relative
JPS53149945A (en) Preparation of alpha-phenylpropionic acid derivatives
KR850005993A (ko) 인조 대리석의 제조 방법
EP0207405A3 (en) Pharmaceutical combination composition and associated method
IT9022371A0 (it) Derivati dell'1-arilsolfonil 2-pirrolidone, loro procedimento di preparazione e i nuovi intermedi cosi' ottenuti, il loro impiego come farmaci e le composizioni farmaceutiche che li contengono.